
Jin Seok (Andy) Lee
@iam_js_lee
Bioinformatics & Computational Biology PhD Student @pirl_unc
ID: 1207514115016519681
http://andyjslee.com 19-12-2019 04:14:28
112 Tweet
146 Followers
462 Following

🚨 Excited to share our latest paper in Cell identifying how under-replicated chromosomes in micronuclei become shattered by the Fanconi anemia pathway during mitosis. This work was led by UTSW Graduate School of Biomedical Sciences student Justin Engel. 🧵 (1/13): cell.com/cell/fulltext/…

As we look to optimize more of Minimap2 on the GPUs in mm2-gb, we are looking for feedbacks from our user community. Please feel free to reach out to us. github.com/Minimap2onGPU/… Joy Dong , Gina Sitaraman , AMD , University of Michigan Oxford Nanopore




SPECIAL ISSUE! This month Genome Research publishes a diverse collection of research and review articles in a special issue highlighting advances in long-read sequencing applications in biology and medicine. tinyurl.com/Genome-Res-34-….


Here's our latest, led by Drs. Riaz Gillani & Ryan Collins - we studied a type of inherited genetic event (structural variants) + risk of developing certain cancers in kids: Dana-Farber News Dana-Farber Division of Population Sciences Boston Children's Broad Institute Science Magazine science.org/doi/10.1126/sc…


We're thrilled to present ESM3 in Science Magazine. ESM3 is a generative language model that reasons over the three fundamental properties of proteins: sequence, structure, and function. Today we're making ESM3 available free to researchers worldwide via the public beta of an API



Extremely excited re: IMA203 - PRAME TCR T cells Ph 1 study published in Nature Medicine! This is a transformative Rx in #melanoma for HLA-A201+ & PD1 refractory pts. Compared to TIL, easier to make, less toxic & so far ~2x response rate in heavily pre-Rx. nature.com/articles/s4159…


New paper by Dr. Amy Pomeroy! A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma Out now in Blood Cancer Discovery Blood Cancer Discovery doi.org/10.1158/2643-3… #mathonc #lymsm #BloodCancer 1/n

🚨Today in Cell, we show that RNA splicing factor mutations in myeloid cancers generate splicing-derived public neoantigens targetable by #TCR tx. Amazing collaboration co-led by Abdel-Wahab Lab, Robert K. Bradley, and Klebanoff_Lab. #Tcellpower cell.com/cell/fulltext/…

Took a year but today marks a very special day for Jin Seok (Andy) Lee and I. ACE may be used as a *teenie* part of a clinical trial. Confronted with the slim possibility of actually making a fraction of a difference and suddenly the months of sleepless nights don’t seem all that bad 🥲

After next round of the bake-off, going to pivot to tumor antigens (once we get some mass spec validation of which ones are real). For now, read the blog post by Benjamin Vincent: pirlblog.substack.com/p/an-experimen…

Update to our software for predicting tumor antigens using genomics data (LENS v1.7), done by Steven Vensko II - Now with native package support for HLApollo, pepsickle, and RNA-only analysis (+ fixes and improvements) pirlblog.substack.com/p/announcing-l… alex rubinsteyn Jin Seok (Andy) Lee dhuv.io

